BackU.S. Stem Cell Overview

U.S. Stem Cell Common Stock

Latest common stock for USRM: $630K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$634403.00
↑ 25.99% YoYΔ $130878.00 vs prior year quarter

Peer trimmed avg / median

Loading

U.S. Stem Cell Common Stock History

Loading

U.S. Stem Cell vs. peers: Common Stock Comparison

Loading

U.S. Stem Cell Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

U.S. Stem Cell (USRM) FAQ

U.S. Stem Cell (USRM) currently reports a common stock of $630K as of December 2022. That compares with $500K in the prior-year period — up 26.0% year over year. Use the charts on this page to explore U.S. Stem Cell's common stock history and peer comparisons.

U.S. Stem Cell's common stock increased from $500K to $630K — a 26.0% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

U.S. Stem Cell reported $630K in common stock as of December 2022. That compares with $500K in the prior-year period — up 26.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $630K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for U.S. Stem Cell, and consider following USRM for alerts when major investors trade the stock.

U.S. Stem Cell is classified in the Healthcare sector. On common stock, it currently shows $630K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing USRM with unrelated industries.